Chemical Engineering Journal, Год журнала: 2024, Номер 500, С. 157464 - 157464
Опубликована: Ноя. 1, 2024
Язык: Английский
Chemical Engineering Journal, Год журнала: 2024, Номер 500, С. 157464 - 157464
Опубликована: Ноя. 1, 2024
Язык: Английский
Chemical Engineering Journal, Год журнала: 2025, Номер 505, С. 159400 - 159400
Опубликована: Янв. 9, 2025
Язык: Английский
Процитировано
0New Journal of Chemistry, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
The study presents a Fe 3 O 4 @C@Pt nanozyme, modified with folic acid, that efficiently targets tumor cells and inhibits growth through combined photothermal therapy catalysis.
Язык: Английский
Процитировано
0ACS Applied Materials & Interfaces, Год журнала: 2025, Номер unknown
Опубликована: Янв. 14, 2025
Alveolar echinococcosis (AE) is a serious parasitic infectious disease that highly invasive and destructive to the liver has high mortality rate. However, currently, there no effective targeted imaging treatment method for precise detection therapy of AE. We proposed new two-step targeting strategy (TSTS) AE based on poly(lactic-co-glycolic acid) (PLGA). designed constructed novel type ICG@PLGA@Lips nanoprobe with integrated properties. First, we used characteristics PLGA gluconeogenic raw material target during blood circulation. Then, utilized specifically penetrating shell achieve specific identification in liver. Under 808 nm laser excitation, effectively achieved accurate near-infrared II (NIR-II, 900-1700 nm) fluorescence methods through PDT effects. improved optical properties ICG, while liposomes further biocompatibility nanoprobe. As showed strong NIR-II emission good biocompatibility, advantages navigation surgical resection lesions. Thus, assistance ICG@PLGA@Lips, real-time first time. successfully obtained vivo imaging-guided photodynamic/surgical This TSTS-based exploration provided early AE, which expected significantly improve prognosis patients.
Язык: Английский
Процитировано
0Journal of environmental chemical engineering, Год журнала: 2025, Номер unknown, С. 115362 - 115362
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 161732 - 161732
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 13
Опубликована: Апрель 15, 2025
Lung cancer is a major malignancy that poses significant threat to human health, with its complex pathogenesis and molecular characteristics presenting substantial challenges for treatment. Traditional two-dimensional cell cultures animal models are limited in their ability accurately replicate the of different lung patients, thereby hindering research on disease mechanisms treatment strategies. The development organoid technology has enabled growth patient-derived tumor cells three-dimensional cultures, which can stably preserve tumor’s tissue morphology, genomic features, drug response. There have been advancements field organoids (PDLCOs), remain reproducibility standardization PDLCOs due variations specimen sources, subsequent processing techniques, culture medium formulations, Matrigel batches. This review summarizes cultivation validation processes explores clinical applications personalized treatment, screening after resistance, biobanks construction, development. Additionally, integration cutting-edge technologies various fields, such as assembloid artificial intelligence, organoid-on-a-chip, 3D bioprinting, gene editing, single-cell RNA sequencing, greatly expanded potential. review, incorporating latest developments PDLCOs, provides an overview cultivation, applications, interdisciplinary integration, while also addressing prospects precision medicine cancer.
Язык: Английский
Процитировано
0Chemical Engineering Journal, Год журнала: 2024, Номер 500, С. 157464 - 157464
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
3